miRNA‐130b‐5p promotes hepatic stellate cell activation and the development of liver fibrosis by suppressing SIRT4 expression
Open Access
- 17 July 2021
- journal article
- research article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 25 (15) , 7381-7394
Abstract
Liver fibrosis is a progressive disease accompanied by the deposition of extracellular matrix (ECM). Numerous reports have demonstrated that alterations in the expression of microRNAs (miRNAs) are related to liver disease. However, the effect of individual miRNAs on liver fibrosis has not been studied. Hepatic stellate cells (HSCs), being responsible for producing ECM, exert an important influence on liver fibrosis. Then, microarray analysis of non‐activated and activated HSCs induced by transforming growth factor β1 (TGF‐β1) showed that miR‐130b‐5p expression was strongly up‐regulated during HSC activation. Moreover, the progression of liver fibrosis had a close connection with the expression of miR‐130b‐5p in different liver fibrosis mouse models. Then, we identified that there were specific binding sites between miR‐130b‐5p and the 3′ UTR of Sirtuin 4 (SIRT4) via a luciferase reporter assay. Knockdown of miR‐130b‐5p increased SIRT4 expression and ameliorated liver fibrosis in mice transfected with antagomiR‐130b‐5p oligos. In general, our results suggested that miR‐130b‐5p promoted HSC activation by targeting SIRT4, which participates in the AMPK/TGF‐β/Smad2/3 signalling pathway. Hence, regulating miR‐130b‐5p maybe serve as a crucial therapeutic treatment for hepatic fibrosis.Keywords
Funding Information
- Foundation for Innovative Research Groups of the National Natural Science Foundation of China (81571546, 81971495, 91442117)
This publication has 38 references indexed in Scilit:
- Suppression of oxidative stress and improvement of liver functions in mice by ursolic acid via LKB1‐AMP‐activated protein kinase signalingJournal of Gastroenterology and Hepatology, 2015
- Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysisBMC Medicine, 2014
- MicroRNAs in liver diseaseNature Reviews Gastroenterology & Hepatology, 2013
- Role of Binding and Nucleoside Diphosphate Kinase A in the Regulation of the Cystic Fibrosis Transmembrane Conductance Regulator by AMP-activated Protein KinaseJournal of Biological Chemistry, 2012
- Metformin attenuates ventricular hypertrophy by activating the AMP‐activated protein kinase–endothelial nitric oxide synthase pathway in ratsClinical and Experimental Pharmacology and Physiology, 2010
- Evolving challenges in hepatic fibrosisNature Reviews Gastroenterology & Hepatology, 2010
- Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosisJournal of Gastroenterology and Hepatology, 2007
- Liver fibrosisJournal of Clinical Investigation, 2005
- Role of Smad4 on TGF-β–induced extracellular matrix stimulation in mesangial cellsKidney International, 2003
- microRNAsCell, 2001